4 Results for "

LCLC-103H

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "LCLC-103H" in MCE Product Catalog:

Cat. No.: HY-W016889
CAS No.: 708-06-5
Target:  

Ras

Research Areas:  

Cancer

CFL-137 is a potent KRas G12C inhibitor. CFL-137 shows an antiproliferative effect. CFL-137 shows anticancer activity. CFL-137 has the potential for the research of lung cancer .
loading...
    loading...
Cat. No.: HY-145622
CAS No.: 2460400-64-8
Synonyms: BA3011; CAB-Axl-ADC; CAB-anti-Axl-ADC
Mecbotamab vedotin (BA3011) is a pH dependent antibody drug conjugate (ADC) targeting AXL. Mecbotamab vedotin can significantly inhibit AXL in DU145 cells and LCLC-103H cells and kills cells. Mecbotamab vedotin can be used for research on cancer such as lung cancer, pancreatic cancer and prostate cancer. The antibody component is Mecbotamab (HY-P9988), and the ADC toxin molecule is Monomethyl auristatin E (MMAE) (HY-15162) .
loading...
    loading...
Cat. No.: HY-W041315
CAS No.: 18711-15-4
Target:  

Ras

Research Areas:  

Cancer

CFL-120 is a potent KRas G12C inhibitor. CFL-120 shows an antiproliferative effect. CFL-120 shows anticancer activity. CFL-120 has the potential for the research of lung cancer .
loading...
    loading...
Cat. No.: HY-W016889R
CAS No.: 708-06-5
Target:  

Reference Standards Ras

Research Areas:  

Cancer

CFL-137 is a potent KRasG12C inhibitor. CFL-137 shows an antiproliferative effect. CFL-137 shows anticancer activity. CFL-137 has the potential for the research of lung cancer .
loading...
    loading...